Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $61.53 million. The enterprise value is -$6.17 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 18.31 million shares outstanding. The number of shares has increased by 339.24% in one year.
| Current Share Class | 18.31M |
| Shares Outstanding | 18.31M |
| Shares Change (YoY) | +339.24% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 66.97% |
| Float | 13.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.51 |
| Forward PS | 0.47 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.80.
| Current Ratio | 6.67 |
| Quick Ratio | 5.24 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.78 |
Financial Efficiency
Return on equity (ROE) is -106.20% and return on invested capital (ROIC) is -18.25%.
| Return on Equity (ROE) | -106.20% |
| Return on Assets (ROA) | -15.43% |
| Return on Invested Capital (ROIC) | -18.25% |
| Return on Capital Employed (ROCE) | -29.41% |
| Weighted Average Cost of Capital (WACC) | 12.75% |
| Revenue Per Employee | $385,406 |
| Profits Per Employee | -$263,397 |
| Employee Count | 310 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, Outset Medical has paid $718,000 in taxes.
| Income Tax | 718,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.41% in the last 52 weeks. The beta is 2.10, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | -59.41% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 10.64 |
| Relative Strength Index (RSI) | 43.53 |
| Average Volume (20 Days) | 239,148 |
Short Selling Information
The latest short interest is 1.92 million, so 10.46% of the outstanding shares have been sold short.
| Short Interest | 1.92M |
| Short Previous Month | 2.22M |
| Short % of Shares Out | 10.46% |
| Short % of Float | 14.66% |
| Short Ratio (days to cover) | 5.39 |
Income Statement
In the last 12 months, Outset Medical had revenue of $119.48 million and -$81.65 million in losses. Loss per share was -$5.37.
| Revenue | 119.48M |
| Gross Profit | 46.75M |
| Operating Income | -66.71M |
| Pretax Income | -80.94M |
| Net Income | -81.65M |
| EBITDA | -62.37M |
| EBIT | -66.71M |
| Loss Per Share | -$5.37 |
Full Income StatementBalance Sheet
The company has $168.95 million in cash and $101.25 million in debt, with a net cash position of $67.70 million or $3.70 per share.
| Cash & Cash Equivalents | 168.95M |
| Total Debt | 101.25M |
| Net Cash | 67.70M |
| Net Cash Per Share | $3.70 |
| Equity (Book Value) | 126.95M |
| Book Value Per Share | 6.99 |
| Working Capital | 213.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$46.33 million and capital expenditures -$798,000, giving a free cash flow of -$47.13 million.
| Operating Cash Flow | -46.33M |
| Capital Expenditures | -798,000 |
| Depreciation & Amortization | 4.34M |
| Net Borrowing | -106.68M |
| Free Cash Flow | -47.13M |
| FCF Per Share | -$2.57 |
Full Cash Flow StatementMargins
Gross margin is 39.13%, with operating and profit margins of -55.84% and -68.34%.
| Gross Margin | 39.13% |
| Operating Margin | -55.84% |
| Pretax Margin | -67.74% |
| Profit Margin | -68.34% |
| EBITDA Margin | -52.21% |
| EBIT Margin | -55.84% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -339.24% |
| Shareholder Yield | -339.24% |
| Earnings Yield | -132.71% |
| FCF Yield | -76.59% |
Analyst Forecast
The average price target for Outset Medical is $13.33, which is 296.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.33 |
| Price Target Difference | 296.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 11.48% |
| EPS Growth Forecast (5Y) | -45.10% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -4.75 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.75 |
| Piotroski F-Score | 5 |
